Leuprorelin
Also known as: Leuprolide · Lupron · Eligard
A potent GnRH agonist used for prostate cancer, endometriosis, precocious puberty, and gender-affirming hormone suppression.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~3 hours
3.75–22.5 mg depot monthly/quarterly
IM or SC depot injection
Mechanism of Action
Continuous GnRH receptor stimulation causes initial flare then complete pituitary desensitization, achieving reversible chemical castration.
Key Research Areas
Frequently Asked Questions
What is Leuprorelin?▾
How does Leuprorelin work?▾
What is the recommended dosage for Leuprorelin?▾
What is the half-life of Leuprorelin?▾
Is Leuprorelin FDA approved?▾
Research Disclaimer
The information provided about Leuprorelin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.